Program Director
Valentin Fuster, MD, PhD, FACC
Director, Zena and Michael A. Wiener Cardiovascular Institute
Mt. Sinai Medical Center, New York
Faculty
David H. Adams, M.D., F.A.C.C.
Marie-Josée and Henry R. Kravis Professor
Chairman, Department of Cardiothoracic Surgery
Mt. Sinai Medical Center, New York
Elliott M. Antman, M.D., F.A.C.C.
Professor of Medicine, Harvard Medical School
Senior Investigator, TIMI Study Group
Director, Samuel A. Levine Cardiac Unit, Brigham and Women’s Hospital
Boston, MA
Deepak L. Bhatt, M.D., F.AC.C., F.S.C.A.I., F.E.S.C., F.A.C.P.
Associate Director, Cleveland Clinic Cardiovascular Coordinating Center
Staff, Cardiac, Peripheral, and Carotid Intervention
Associate Professor of Medicine
Department of Cardiovascular Medicine
Cleveland Clinic Foundation
Jeffrey S. Borer, M.D., F.A.C.C.
Gladys and Roland Harriman Professor of Cardiovascular Medicine
Chief, Division of Cardiovascular Pathophysiology
Director, The Howard Gilman Institute for Valvular Heart Diseases
Weill Medical College of Cornell University, New York
Eugene Braunwald, M.D., M.A.C.C.
Distinguished Hersey Professor of Medicine
Harvard Medical School
Chairman, TIMI Study Group
Brigham and Women's Hospital, Boston, Mass.
Michael R. Bristow, M.D., Ph.D., F.A.C.C.
Professor of Medicine/Cardiology
Co-Director, University of Colorado Cardiovascular Institute
Christopher Cannon, M.D., F.A.C.C.
TIMI Study Group, Cardiovascular Division
Brigham and Women's Hospital, Boston, Mass.
Alain Carpentier, M.D., Ph.D., F.A.C.C.
Professor, University of Paris
Hopital Europeen Georges Pompidou
Paris, France
Leslie T. Cooper, Jr., M.D., F.A.C.C.
Associate Professor of Medicine
Mayo College of Medicine
Consultant, Cardiovascular Diseases
Mayo Clinic, New York
Gregory J. del Zoppo, M.D., M.S.
Associate Professor, Division of Molecular and Experimental Medicine
The Scripps Research Institute
Jean-Pierre Després, Ph.D., F.A.H.A.
Director of Research
Québec Heart Institute, Canada
Thomas G. DiSalvo, M.D.
Medical Director
Vanderbilt Heart Institute
Associate Professor of Medicine
Vanderbilt University School of Medicine
Helmut Drexler, M.D.
Professor, Medical University of Hannover, Germany
Thomas Eschenhagen, M.D.
Professor, Head of Institute of Pharmacology
University Medical Center, Hamburg-Eppendorf
Michael E. Farkouh, M.D., M.S.C., F.A.C.C.
Associate Professor of Medicine
Director, Clinical Trials
Mt. Sinai Medical Center, New York
David P. Faxon, M.D., F.A.C.C.
Brigham and Women's Hospital, Boston, Mass.
Arthur M. Feldman, M.D., Ph.D., F.A.C.C.
Chairman, Department of Medicine
Thomas Jefferson University, Jefferson Medical College, Penn.
Curt D. Furberg, M.D., Ph.D.
Professor, Wake Forest University School of Medicine, North Carolina
Randall B. Griepp, M.D.
Professor of Cardiothoracic Surgery
Mt. Sinai Medical Center, New York
Scott M. Grundy, M.D., Ph.D.
Professor, University of Texas Southwestern Medical Center, Texas
Jonathan L. Halperin, M.D., F.A.C.C., F.A.H.A.
Robert and Harriet Heilbrunn, Professor of Medicine (Cardiology)
Mt. Sinai School of Medicine, New York University
Director, Cardiology Clinical Studies
The Zena and Michael A. Wiener Cardiovascular Institute
The Marie Josée and Henry R. Kravis Center for Cardiovascular Health
Mt. Sinai Medical Center, New York
Shinji Kihara, M.D., Ph.D.
Associate Professor
Department of Metabolic Medicine
Graduate School of Medicine
Osaka University
Raymond J. Kim, M.D., F.A.C.C.
Associate Professor, Medicine and Radiology
Duke University Medical Center, North Carolina
Paul Kligfield, M.D., F.A.C.C.
The New York Hospital, Cornell Medical Center, New York
President, New York State Chapter, American College of Cardiology
Donna Mancini, M.D.
Professor of Medicine, Columbia University, New York
Barry J. Maron, M.D., F.A.C.C.
Director, Hypertrophic Cardiomyopathy Centerv
Minneapolis Heart Institute Foundation, Minn.
Pedro R. Moreno, M.D., F.A.C.C.
Director, Interventional Cardiology Research
Associate Professor of Medicine
Mt. Sinai Medical Center, New York
Andrea Natale, M.D., F.A.C.C.
The Cleveland Clinic Foundation
Mohamad Navab, M.D., Ph.D.
Professor of Medicine, UCLA Cardiology, Calif.
Steven E. Nissen, M.D., F.A.C.C.
Interim-Chairman, Department of Cardiovascular Medicine
The Cleveland Clinic Foundation
President, American College of Cardiology
Jeffrey W. Olin, D.O., F.A.C.C.
Professor of Medicine, Director, Vascular Medicine
Zena and Michael A. Wiener Cardiovascular Institute
Marie-Josée and Henry R. Kravis Center for Cardiovascular Health
Mt. Sinai Medical Center, New York
William W. O'Neill, M.D., F.A.C.C., F.S.C.A.I
Executive Dean for Clinical Affairs
Leonard M. Miller School of Medicine
University of Miami, Miami, Florida
Eric N. Prystowsky, M.D., F.A.C.C.
Director, Clinical Electrophysiology Lab
St. Vincent Hospital, Indiana
Consulting Professor of Medicine
Duke University Medical Center, North Carolina
The Care Group, LLC, Indiana
Paul Ridker, M.D., M.P.H., F.A.C.C.
Eugene Brauwald Professor of Medicine
Harvard School of Medicine
Brigham and Women's Hospital, Boston, Mass.
Carlos E. Ruiz., M.D., Ph.D., F.A.C.C.
Professor of Pediatrics and Medicine
University of Illinois at Chicago
Frank M. Sacks, M.D.
Professor of Cardiovascular Disease Prevention
Harvard School of Public Health
Professor of Medicine
Harvard Medical School
Brigham & Women’s Hospital, Boston, Mass.
Laurence S. Sperling, M.D., F.A.C.C., F.A.C.P.
Associate Professor of Medicine
Director of the Center for Heart Disease Prevention
Emory University School of Medicine, Georgia
Paul D. Stein, M.D., F.A.C.C.
Director, Research Education
St. Joseph Mercy-Oakland Hospital, Michigan
Lynne Warner Stevenson, M.D., F.A.C.C.
Director, Cardiomyopathy and Heart Failure Program
Brigham and Women's Hospital, Boston, Mass.
Lars Wallentin, M.D.
Professor of Cardiology
Uppsala Clinical Research Center, Sweden
Roberta G. Williams, M.D., F.A.C.C., M.A.H.A
Professor and Chair, Department of Pediatrics
Keck School of Medicine, USC
Vice President for Academic Affairs, Children's Hospital, Los Angeles
Clyde W. Yancy, Jr., M.D., F.A.C.C., F.A.H.A., F.A.C.P.
Professor of Medicine, University of Texas Southwestern Medical Center
James B. Young, Jr., M.D., F.A.C.C.
Professor and Chairman, Division of Medicine
The Cleveland Clinic Foundation
|
The 39th Annual New York Cardiovascular
Symposium
Dec. 8-10, 2006
Hilton New York, New York City
 Program Overview & Description
Over 40 cardiovascular experts come together for this three-day, interactive educational event, designed to provide a comprehensive review of major topics in cardiology today, including the latest diagnostic, therapeutic and preventive approaches for coronary heart disease and systemic arterial disease. Attendees will explore significant aspects of cardiac and electrical failure; structural heart disease, including the optimal approach and management of valvular heart disease, as well as the evolving role of percutaneous valve replacement; aortic aneurysm; and atrial fibrillation.
Faculty will also discuss and debate various modalities for identifying biochemical and bioimaging markers as well as genetic markers as an advance to risk. The program covers evolving preventive strategies, with special emphasis on hypertension, diabetes, obesity and tobacco use. A highlight of the meeting is a seminar devoted to the top 10 cutting-edge topics with particular emphasis on genetics and evolving cell therapy, as well as key diagnostic and therapeutic developments, trends in outcomes, economics and the burden of cardiovascular diseases.
Target Audience
This course is designed for cardiovascular specialists, internists, and family physicians.
Program Objectives
Upon completion of this program, attendees should be able to:
Identify and evaluate patients with cardiovascular disease, based on clinical guidelines and best practices for their optimal management, in each of the following categories:
- Acute coronary syndromes and chronic atherothrombotic disease
- Patients with intense biomarkers and bioimaging of disease
- Risk and preventive strategies focused on diabetes, obesity, hypertension and tobacco use
- Valvular heart disease and aortic aneurysm
- Heart failure, including characterization, role of inflammation and immunity, and evolution in management
- Electrical failure
- Atrial fibrillation
Incorporate new advances at the cutting edge into their daily practice:
- Renovating the heart with new cells
- Engineering myocardial tissue
- Role of vasa vasorum
- Role of the PPARs nuclear receptor
- Role of adipocytokines in the metabolic syndrome
- New therapeutic implications of oral HDL-C
- Myocardial viability and microvascular obstruction at MRI
- New advances in the understanding and management of pulmonary embolism
- Neurovascular protection
- The evolving field of congenital heart disease in the adult
39th Annual New York Cardiovascular Symposium
All sessions will be held at the Hilton New York, 1335 Avenue of the Americas, New York, NY 10019.
Views expressed in this program are those of the individual speakers and do not necessarily reflect views of the ACCF.
Schedule
THURSDAY | FRIDAY | SATURDAY | SUNDAY
Thursday, Dec. 7
5:00-8:00 p.m.
Early Registration - Location TBA
Friday, Dec. 8
6:45 a.m.
Registration - Third Floor Promenade
Continental Breakfast - Third Floor Promenade
Introductions
7:30 a.m.
Jack Lewin, M.D.
Chief Executive Officer, American College of Cardiology
Steven E. Nissen, M.D., F.A.C.C.
President, American College of Cardiology
Paul Kligfield, M.D., F.A.C.C.
President, New York State Chapter
American College of Cardiology
Coronary Artery Disease
Challenges in 2006, Opportunities for the Future
Part I: Acute Coronary Syndromes
Dr. Braunwald, Presiding
7:45 a.m.
Cellular and Molecular Basis of Atherothrombosis:
From Treatment of the Complicated Plaques to Prevention of the Early Lesions
Dr. Fuster
8:10 a.m.
IVUS Assessment of Atherosclerosis: What Have We Learned?
Dr. Nissen
8:35 a.m.
STEMI --The Challenge of Timing for Reperfusion: Community and Practical
Strategies
Dr. Faxon
9:00 a.m.
STEMI: The 2006 New Aspects in Pharmacological Management
Dr. Antman
9:25 a.m.
NSTE-ACS: Stratification for Selection of Patients for Intervention
Dr. O'Neill (An American View)
Dr. Wallentin (A European View)
9:55 a.m.
NSTE-ACS: The 2006 New Aspects in Pharmacological Management
Dr. Cannon
10:15 a.m.
Coffee Break
10:30 a.m.
Stable Angina: Is the Management Biased by ACS Trials?
Are There New Antianginal Approaches?
Dr. Braunwald
10:55 a.m.
Aspirin and Clopidogrel Resistance: An Emerging Clinical Entity
Dr. Bhatt
11:20 a.m.
Panel Discussion
Drs. Fuster, Nissen, Faxon, Antman, O’Neill, Wallentin, Cannon, Braunwald and Bhatt
12:00 p.m.
Luncheon
Coronary Artery Disease
Challenges in 2006, Opportunities for the Future
Part II: Chronic Coronary and Systemic Arterial Disease
Dr. Ridker, Presiding
Evolving Tools of Identification and Prognosis
1:00 p.m.
From Risk Factors to Biochemical and Bioimaging Markers
Dr. Fuster
1:20 p.m.
Carotid, Aortic and Peripheral Vascular Disease:
Powerful Markers of Coronary Disease & Prognosis
Dr. Olin
1:40 p.m.
From Risk Factors to Genetic Testing
Dr. Ridker
2:00 p.m.
Panel Discussion
Drs. Fuster, Olin and Ridker
2:25 p.m.
Coffee Break
Trends and Challenges of Management
2:45 p.m.
Recent Trials in Hypertension: Compelling Science or Commercial Speech
Dr. Furberg
3:05 p.m.
Making Abdominal Obesity a New Therapeutic Target for the Optimal Management
of CVD Risk: Role of the CB1-blocker Rimonabant
Dr. Després
3:25 p.m.
Diet and Overweight: Evidence based Assessment of the Various Diets — “Please, eatless”
Dr. Sperling
3:45 p.m.
Tell Us and the Public About Homocysteine, Vitamins and Antioxidants, Soy Proteins
and Isoflavones
Dr. Sacks
4:05 p.m.
Diabetes Medical Management: Are Cardiologists Ready to Take the Lead?
Dr. Farkouh
4:25 p.m.
PAUL DUDLEY WHITE LECTURE
From Treatment to Promotion of Health
Dr. Grundy
4:55 p.m.
Panel Discussion
Drs. Furberg, Després, Sperling, Sacks, Farkouh and Grundy
5:30 p.m.
Adjourn
Saturday, Dec. 9
6:45 a.m.
Continental Breakfast
Heart and Electrical Failure 2006
Dr. Stevenson, Presiding
Characterization of Heart Failure and Basis for Management
7:30 a.m.
Biochemical Pathways, Genomics and Proteomics:
Helpful for the Clinician or for the Researcher
Dr. Bristow
Humoral and Hormonal Pathways: Helpful for the Prognosis
Dr. Feldman
Hemodynamic Patterns: Relevant in Tailoring Therapy
Dr. Stevenson
Clinical Stages A to D: How to Prevent Hospitalization; Home Quality Management
Dr. Yancy
In 2006, What is Debatable for the Patient with Left Ventricular Dysfunction?
9:10 a.m.
Oral Anticoagulants?
Dr. Fuster
Implantable Cardioverter: Defibrillator and/or Resynchronization Pacing?
Dr. Prystowsky
Surgical Remodeling?
Dr. Young
10:10 a.m.
Coffee Break
Cardiomyopathy, Inflammation and Immunity: What is Clearly New
10:35 a.m.
New ACC/AHA Classification
Dr. Maron
Myocarditis and Dilated Cardiomyopathy
Dr. Cooper
Restrictive Cardiomyopathy
Dr. Mancini
11:20 a.m.
Panel Discussion
Drs. Bristow, Feldman, Stevenson, Yancy, Fuster, Prystowsky, Young, Maron,
Cooper and Mancini
12:00 p.m.
Luncheon
Valvular Heart Disease
Challenges in 2006
Dr. Carpentier, Presiding
1:00 p.m.
Timing of Indications for Valvular Heart Surgery: Should We Advance the Clock
Dr. Borer
1:25 p.m.
Approaches to The Dilated Thoracic Aorta: Should We Also Advance the Clock
Dr. Griepp
1:50 p.m.
The Future of Aortic Valve Repair, Mechanical Prostheses and Pericardial Prostheses:
Guess the Big Winner
Dr. Carpentier
2:15 p.m.
What the Cardiologist and Cardiac Surgeon Should Know About Degenerative
Mitral Valve Disease
Dr. Adams
2:40 p.m.
Novelties for Percutaneous Aortic Valve and Mitral Valve Replacement
Dr. Ruiz
3:05 p.m.
Panel Discussion
Drs. Borer, Griepp, Carpentier, Adams and Ruiz
3:35 p.m.
Coffee Break
Atrial Fibrillation
Challenges in 2006
Dr. Halperin, Presiding
3:50 p.m.
Epidemiologic, Scientific and Clinical Challenge
Dr. Fuster
4:10 p.m.
Rate vs. Rhythm Control: Listen Carefully to the Patient, Project at His/Her Future,
Then the Algorithms
Dr. Prystowsky
4:30 p.m.
Anticoagulants for Stroke Prevention: What Guidelines to Follow
Dr. Halperin
4:50 p.m.
The Catheter Ablation as Compared to the Surgical Cox Maze
Procedure in the Treatment of Atrial Fibrillation
Dr. Natale
5:10 p.m.
Panel Discussion
Drs. Fuster, Prystowsky, Halperin and Natale
5:30 p.m.
Adjourn
Sunday, Dec. 10
7:00 a.m.
Continental Breakfast
Year in Revew: Highlights of Progress in 2006
Dr. Fuster, Presiding
Genetics, Cell Regeneration and Molecular Signaling
7:30 a.m.
Cardiac Regeneration: Should We Return to the Basics?
Dr. Drexler
7:50 a.m.
Engineering Myocardial Tissue: Is it Real?
Dr. Eschenhagen
8:10 a.m.
Benefits and Risks of Vasa Vasorum in the Plaque
Dr. Moreno
8:30 a.m.
HENRY I. RUSSEK LECTURE
Oral HDL Cholesterol: A Bright Horizon
Dr. Navab
9:05 a.m.
Coffee Break
Diagnostic / Therapeutics
9:25 a.m.
MRI in the Assessment of Myocardial Viability and Microvascular Obstruction:
An Evolving, Powerful Tool for Diagnosis, Prognosis and Management
Dr. Kim
9:45 a.m.
Novelties for the Diagnostic, Prognostic and Therapeutic Approaches of Pulmonary Embolism
Dr. Stein
10:05 a.m.
Novelties for the Diagnostic, Prognostic and Therapeutic Approaches of Myocarditis
Dr. DiSalvo
10:25 a.m.
Adipocytokines in Metabolic Syndrome and Related Cardiovascular Disease
Dr. Kihara
The Burden of Cardiovascular Disease is Beyond Adult Cardiology
10:45 a.m.
Stroke and Neurovascular Protection: Focus on Research or a Clinical Reality
Dr. del Zoppo
11:05 a.m.
Report from NHLBI in Adult Congenital Heart Disease: What is the Direction?
Dr. Williams
11:45 a.m.
Adjournment, Program Evaluation and CME Credit
Accreditation
The American College of Cardiology Foundation (ACCF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The ACCF designates this educational activity for a maximum of 23.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credits commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 credit.
While offering CME credits noted above, the program is not intended to provide extensive training or certification in this field.
PROGRAM INFORMATION
Group Registrations
Please contact Susie Brenner, The Housing Connection. E-mail sbrenner@saltlake.org; Phone (801) 534-4985.
Fees
Please see the application for detailed registration fees.
Registrations will be confirmed via e-mail, fax or mail. The deadline to register is Nov. 28, 2006. After this date, you must register on site, and an additional $100 processing fee will apply. Please be aware that date of postmark does not indicate date of receipt.
Program Cancellations
Cancellation, substitution or transfer to another course is allowed if written cancellation is received on or before Nov. 14, 2006. A refund, minus a $50 processing fee, will be given for cancellations received on or before Nov. 14, 2006. A full refund, minus a $100 processing fee, will be given for written cancellations received after Nov. 14, 2006. No refunds will be given for no shows.
In the unlikely event that the program is cancelled, the College will refund the registration fee in full but is not responsible for any travel or hotel costs you may incur.
Please Note
Smoking is prohibited in all ACCF meeting rooms. Videotaping and still photography are prohibited in all ACCF meeting rooms. Audiotaping is permitted.
HOTEL INFORMATION & POLICIES
Those requesting a room must first register for the program.
Each registrant may reserve ONE room at the conference rate as long as rooms are available. One additional room, if available, will be at the rate set by the hotel.
A TWO NIGHT MINIMUM STAY is required.
Reservations will not be accepted without a credit card guarantee or a check for one night’s room plus tax for each room reserved.
We reserve the right to release a reservation for which payment (check or credit card) has been declined.
Deadline
All rooms will be booked on a first-come first-served basis and are subject to availability.
Rooms at the conference rate are available until Oct. 26, 2006 — or earlier if the block sells out.
Changes and substitutions must be made by phone, fax, mail or Internet by Nov. 14, 2006 in order to guarantee convention rates. After Nov. 14, 2006 please contact the hotel directly.
Confirmation
THC will send you a confirmation of your reservation. Please review all information for accuracy.
E-mail confirmations will be sent if an e-mail address is provided (preferred), or they can be faxed or mailed.
If you do not receive a confirmation or have questions, please call THC at (888) 221-9425 or (801) 521-9025. You will not receive a confirmation from the hotel.
Rate, Tax & Charges
The room rate at the Hilton New York is $390 plus tax and additional charges.
The room rate at the Sheraton New York is $410 plus tax and additional charges.
All rates are per room and are subject to 13.37% tax (subject to change) as well as a $2.00 occupancy charge.
Special requests cannot be guaranteed; however, hotels will do their best to honor all requests.
Hotels will assign specific rooms upon check-in, based on availability.
Booked Hotel Cancellations
All cancellations must be submitted in writing.
For cancellations received AFTER Nov. 14, 2006: |
- Those who have guaranteed their reservation by credit card will be charged one night’s room and tax for each room reserved.
- Those who have paid by check will forfeit the one night’s deposit(s) paid.
|
No shows: If you do not arrive at the hotel on the date indicated you will forfeit your deposit and the hotel will cancel your room reservation.
Disclaimer: In the unlikely event that the program is cancelled, the American College of Cardiology and The Housing Connection are not responsible for any travel or hotel costs you may incur.
Henry I. Russek Travel Award
Each year, a limited number of Fellows in Training receive this prestigious award, providing funding to attend the New York Cardiovascular Symposium. The award honors Dr. Henry I. Russek, who served as Director of the New York Cardiovascular Symposium for 24 years. For more information, visit http://www.acc.org/about/award/awardopps.htm#russek.
Acknowledgment
ACCF Imaging Champion
Special thanks to the following companies for their generous support of ACCF image-related programs in 2006:
Major program support is provided by the following company:
Appreciation is also expressed to the following companies for program support:
AstraZeneca LP, Bayer HealthCare LLC, Boston Scientific Corporation, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Daiichi Sankyo, Inc. & Eli Lilly and Company, Eli Lilly and Company, GlaxoSmithKline, King Pharmaceuticals, Inc., The Medicines Company, Inc., Medtronic, Inc., Merck & Co., Inc., Merck/Schering-Plough Pharmaceuticals, Reliant Pharmaceuticals, Inc., sanofi-aventis U.S. Inc., Scios, Inc., Takeda Pharmaceuticals North America, Inc.
ACCF reserves the right to modify faculty and program without notice. The views expressed in this program are those of the individual speakers and do not necessarily reflect the views of the ACCF.
Space is limited, so register early.
|
